4.6 Article

New tricyclic systems as photosensitizers towards triple negative breast cancer cells

Journal

ARCHIVES OF PHARMACAL RESEARCH
Volume 45, Issue 11, Pages 806-821

Publisher

PHARMACEUTICAL SOC KOREA
DOI: 10.1007/s12272-022-01414-1

Keywords

Pyrrolo[1; 2-h][1; 7]naphthyridinone; Pyrido[2; 3-c]pyrrolo[1; 2-a]azepinone; Photosensitizing agents; Phototoxic activity; Triple-negative breast cancer; MDA-MB-231

Funding

  1. Universita degli Studi di Palermo within the CRUI-CARE Agreement

Ask authors/readers for more resources

New tricyclic compounds, pyrrolo[1,2-h][1,7]naphthyridinones and pyrido[2,3-c]pyrrolo[1,2-a]azepinones, were synthesized as potential photosensitizing agents. They showed photoantiproliferative activity against triple-negative breast cancer cells through the generation of reactive oxygen species and induction of apoptosis.
Nineteen pyrrolo[1,2-h][1,7]naphthyridinones and pyrido[2,3-c]pyrrolo[1,2-a]azepinones were synthesized as new tricyclic systems in which the pyridine ring is annelated to the 6,7-dihydroindolizin-8(5H)-one and 5,6,7,8-tetrahydro-9H-pyrrole[1,2-a]azepine-9-one moieties to obtain potential photosensitizing agents. They were tested for their photoantiproliferative activity on a triple-negative breast cancer cell line, MDA-MB-231, in the dark and under UVA light (2.0 J/cm(2)). We demonstrated that their toxicity, only when exposed to light, was primarily due to the generation of reactive oxygen species while their photodegradation products were not responsible for their activity. The most active compounds exhibited photocytotoxicity with IC50 values at low micromolar level inducing a decrease in the intracellular content of thiol, thus triggering cancer cell death through apoptosis. All the pyridone derivatives revealed to be pure photosensitizers with preferential photocytotoxic activity towards cancerous over healthy cells. Altogether, the results obtained confirm pyrrolo[1,2-h][1,7]naphthyridinones and pyrido[2,3-c]pyrrolo[1,2-a]azepinones as promising photosensitisers against triple-negative breast cancer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available